Bone mesenchymal stem cells (BMSCs)-derived exosomal microRNA-21-5p regulates Kruppel-like factor 3 (KLF3) to promote osteoblast proliferation in vitro
- PMID: 35549815
- PMCID: PMC9310648
- DOI: 10.1080/21655979.2022.2067286
Bone mesenchymal stem cells (BMSCs)-derived exosomal microRNA-21-5p regulates Kruppel-like factor 3 (KLF3) to promote osteoblast proliferation in vitro
Abstract
Bone mesenchymal stem cells (BMSCs)-derived exosomes (Exos) play important roles in osteoporosis, while the regulation of microRNA (miR)-21-5p remains unclear. The BMSCs-derived exosomes were isolated from femoral bone marrow of trauma patients, which were then used to stimulate human osteoblasts (hFOB1.19 cells). The miR-21-5p mimic or inhibitor was transfected into BMSCs to overexpress or knockdown miR-21-5p. The functions of miR-21-5p in osteoporosis were assessed by cell counting kit-8 (CCK-8) assay, alkaline phosphatase (ALP) staining and alizarin red staining assays. We found that BMSCs-derived exosomes could enhance proliferation, osteoblastic differentiation and ALP activity of hFOB1.19 cells. BMSCs-derived exosomes with upregulated miR-21-5p could further enhance these protective impacts compared with that in BMSCs-derived exosomes, while BMSCs-derived exosomes with downregulated miR-21-5p reduced these cell phenotypes. MiR-21-5p could directly bind to the 3'-untranslated region (UTR) of Kruppel-like factor 3 (KLF3), and knockdown of KLF3 obviously attenuated these inhibitory effects of BMSCs-derived exosomes with downregulated miR-21-5p on osteoblastic differentiation and ALP activity of hFOB1.19 cells. In summary, BMSCs-derived exosomal miR-21-5p improved osteoporosis through regulating KLF3, providing a potential therapeutic strategy for osteoporosis.
Keywords: Bone mesenchymal stem cells (BMSCs); Kruppel-like factor 3 (KLF3); exosomes; miR-21-5p; osteoporosis.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures






Similar articles
-
Bone marrow mesenchymal stem cell-derived exosomes promote osteoblast proliferation, migration and inhibit apoptosis by regulating KLF3-AS1/miR-338-3p.BMC Musculoskelet Disord. 2024 Feb 9;25(1):122. doi: 10.1186/s12891-024-07236-0. BMC Musculoskelet Disord. 2024. PMID: 38336637 Free PMC article.
-
Bone Marrow Mesenchymal Stem Cells-Derived Exosomal MicroRNA-150-3p Promotes Osteoblast Proliferation and Differentiation in Osteoporosis.Hum Gene Ther. 2021 Jul;32(13-14):717-729. doi: 10.1089/hum.2020.005. Epub 2021 Jan 22. Hum Gene Ther. 2021. PMID: 33107350
-
microRNA-935-modified bone marrow mesenchymal stem cells-derived exosomes enhance osteoblast proliferation and differentiation in osteoporotic rats.Life Sci. 2021 May 1;272:119204. doi: 10.1016/j.lfs.2021.119204. Epub 2021 Feb 10. Life Sci. 2021. PMID: 33581127
-
Potential Effects of Exosomes and their MicroRNA Carrier on Osteoporosis.Curr Pharm Des. 2022;28(11):899-909. doi: 10.2174/1381612828666220128104206. Curr Pharm Des. 2022. PMID: 35088659 Review.
-
Exosome mediated biological functions within skeletal microenvironment.Front Bioeng Biotechnol. 2022 Jul 22;10:953916. doi: 10.3389/fbioe.2022.953916. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35935491 Free PMC article. Review.
Cited by
-
Regenerative properties of bone marrow mesenchymal stem cell derived exosomes in rotator cuff tears.J Transl Med. 2025 Jan 12;23(1):47. doi: 10.1186/s12967-024-06029-2. J Transl Med. 2025. PMID: 39800717 Free PMC article. Review.
-
The Potential of miR-21 in Stem Cell Differentiation and its Application in Tissue Engineering and Regenerative Medicine.Stem Cell Rev Rep. 2023 Jul;19(5):1232-1251. doi: 10.1007/s12015-023-10510-8. Epub 2023 Mar 11. Stem Cell Rev Rep. 2023. PMID: 36899116 Review.
-
ZFP36 regulates the osteogenic differentiation of adipose-derived mesenchymal stem cells in osteoporosis by mediating KLF3 mRNA degradation.Sci Rep. 2025 Apr 24;15(1):14386. doi: 10.1038/s41598-025-98738-x. Sci Rep. 2025. PMID: 40274995 Free PMC article.
-
KLF transcription factors in bone diseases.J Cell Mol Med. 2024 Apr;28(8):e18278. doi: 10.1111/jcmm.18278. J Cell Mol Med. 2024. PMID: 38546623 Free PMC article. Review.
-
microRNAs delivered by small extracellular vesicles in MSCs as an emerging tool for bone regeneration.Front Bioeng Biotechnol. 2023 Aug 31;11:1249860. doi: 10.3389/fbioe.2023.1249860. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37720323 Free PMC article. Review.
References
-
- Cummings SR, Melton LJ.. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359(9319):1761–1767. - PubMed
-
- Wang Y, Tao Y, Hyman ME, et al. Osteoporosis in China. Osteoporos Int. 2009;20(10):1651–1662. - PubMed
-
- Jones TL, Esa MS, Li KHC, et al. Osteoporosis, fracture, osteoarthritis & sarcopenia: a systematic review of circulating microRNA association. Bone. 2021;152:116068. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical